Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits
Open Access
|Apr 2010References
- Bioanalytical method validation. (2001).FDA/CDER/CVM/DHHS.
- Coe J, Brooks P, Vetelino M, Wirtz M, Arnold E, Huang J, Sands S, Davis T, Lebel L, Fox C, Shrinkhande A, Heym J, Schaeffer E, Rollema H, Lu Y, Mansbach R, Chambers L, Rovetti C, and Schulz D. (2005). Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.: 3474-3477.
- Dobreva D, Danchev N, Nikolova I. (2005). Tabex - Sopharma - natural alternative for smoking cessation and treatment of nicotine dependence.: 30-35.
- Gonzales D, Rennard S, Nides M, Oncken C, Azoulay S, Billing C, Watsky E, Gong J, Williams K and Reeves K. (2006). Varenicline, an alpha4beta2 nicotinic acetylocholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. A randomized controlled trial.: 47-55.
- Imming P, Klaperski P, Stubbs M, Seitz G and Gündisch D. (2001). Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.: 375-388.
- Jorenby D, Hays J, Rigotti N, Azoulay S, Watsky E, Williams K, Billing C, Gong J and Reeves K. (2006). Efficacy of varenicline, an αβ-nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial.: 56-63.
- Klocking H, Richter M, and Damm G. (1980). Pharmacokinetic studies withHcytisine.: 312-4.
- Lickint F. (1956). Medikamentöse Unterstützung der Tabakenwöhnung.: 444-448.
- Mokdad A, Marks J, Stroup D and Gerberding J. (2004). Actual causes of death in the United States.: 1238-1245.
- Sariev A, V Zherdev V, Sologova S, Litvin A, Rodionov A, Kolyvanov G and Vasilev A. (1999). Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits.: 59-61.
- Tonstad S, Tønnesen P, Hajek P, Williams K, Billing C and Reeves K. (2006). Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial.: 64-71.
Language: English
Page range: 15 - 20
Published on: Apr 13, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2010 Henri Astroug, Roumiana Simeonova, Lilia Kassabova, Nikolay Danchev, Dobrin Svinarov, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.